A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening
#4PRI RANKED
Most Cited Paper
in Cancer Genomics and Diagnostics
18 Months Post-Publication
Class of 2026
“A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/cancer-genomics-and-diagnostics/2026/
Topics
Colorectal cancer · Circulating tumor DNA · Blood-based biomarkers · Colorectal cancer screening · early detection · Colorectal cancer screening · Advanced neoplasia · Advanced neoplasia · sensitivity · specificity · clinical validity · average-risk screening population · stage I colorectal cancer · stage II colorectal cancer · stage III colorectal cancer · nonadvanced precancerous lesions · screening adherence · colorectal cancer-related mortality · Liquid biopsy · ECLIPSE trial · Guardant Health · Cancer biomarker · DNA methylation · noninvasive cancer screening · coprimary outcomes · positive predictive value · negative predictive value
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Cancer Genomics and Diagnostics Papers, Class of 2026. https://pri.pepkio.com/top-papers/cancer-genomics-and-diagnostics/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459